Steven Leonard Chapman - 03 Nov 2025 Form 4 Insider Report for Natera, Inc. (NTRA)

Reporting relationship: CEO AND PRESIDENT, Director
Issuer ticker: NTRA
Reported as of: 03 Nov 2025
Net transaction value: -$14,071,497
SEC form: 4
Accepted by SEC: 03 Nov 2025, 21:40:05 UTC
Prior SEC filing: 29 Oct 2025
Next SEC filing: 03 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Vincent Fontanilla, Attorney-in-Fact

Key filing fact

Steven Leonard Chapman filed Form 4 for Natera, Inc. (NTRA) on 03 Nov 2025.

Key facts

This page summarizes Steven Leonard Chapman's Form 4 filing for Natera, Inc. (NTRA).
9 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 03 Nov 2025, 21:40.

Change

Previous filing in this sequence was filed on 29 Oct 2025.
Current net transaction value: -$14,071,497.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001711968 Primary reporting owner

Chapman Steven Leonard

Relationship: CEO AND PRESIDENT, Director
Address: C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN
Signature: /s/ Vincent Fontanilla, Attorney-in-Fact
Signature date: 03 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTRA transaction

Common Stock

Options Exercise

Transaction value: $27,113
Shares: +2,084
Change %: +1.4%
Price: $13.01
Shares after: 151,924
Date: 03 Nov 2025
Ownership: Direct

NTRA transaction

Common Stock

Options Exercise

Transaction value: $72,871
Shares: +3,595
Change %: +2.4%
Price: $20.27
Shares after: 155,519
Date: 03 Nov 2025
Ownership: Direct

NTRA transaction

Common Stock

Options Exercise

Transaction value: $17,962,500
Shares: +150,000
Change %: +96%
Price: $119.75
Shares after: 305,519
Date: 03 Nov 2025
Ownership: Direct

NTRA transaction

Common Stock

Sale

Transaction value: $438,635
Shares: -2,215
Change %: -0.72%
Price: $198.03
Shares after: 303,304
Date: 03 Nov 2025
Ownership: Direct
Footnotes: F1, F2

NTRA transaction

Common Stock

Sale

Transaction value: $381,012
Shares: -1,915
Change %: -0.63%
Price: $198.96
Shares after: 301,389
Date: 03 Nov 2025
Ownership: Direct
Footnotes: F1, F3

NTRA transaction

Common Stock

Sale

Transaction value: $31,314,334
Shares: -156,573
Change %: -52%
Price: $200.00
Shares after: 144,816
Date: 03 Nov 2025
Ownership: Direct
Footnotes: F1, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NTRA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -2,084
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 03 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,084
Exercise price: $13.01
Footnotes: F5

NTRA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -3,595
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 03 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,595
Exercise price: $20.27
Footnotes: F5

NTRA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -150,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 03 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 150,000
Exercise price: $119.75
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

The sale of shares on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024. The sale of 150,000 of these shares was governed by the initial plan and not altered by the subsequently amendment.

Footnote F2

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.28 to $198.27 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.44 to $199.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.51 to $200.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The option shares are fully exercisable.

Footnote F6

On January 22, 2021, the Reporting Person was granted performance-based options which vest in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. The performance thresholds were certified on June 28, 2024, March 28, 2025 and September 28, 2025, resulting in the performance-based option being fully vested as of the last performance threshold date.